chrisvoncsefalvay/vaers-outcomes huggingface dataset:
02-24-18 Slight dizziness in the morning. It went away within about 2 hours. 04-04-18 Noted stinging and itching just above my belt line, right side. A pink colored egg-shaped area appeared at this site, approximately 11 cm long by 6 cm wide. This felt and looked the same as when shingles began on my left side, in 1987. I had my wife photo the affected area on 04-04-2018 with my phone.
Runny nose, coughing, numbness in arm (entire), some vomiting with coughing fits. No treatment.
Eye infection; stiff neck and headache; stiff neck and headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adult male patient received bnt162b2 (BNT162B2), administered in arm left, administration date Apr2021 (Lot number: EP6955) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.  The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious), HEADACHE (non-serious) all with onset Apr2021, outcome "recovered" (2021) and all described as "stiff neck and headache"; EYE INFECTION (non-serious), outcome "unknown", described as "Eye infection".  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021565358 same patient/reporter; different vaccine dose/AE
Narrative:  86 yo patient reported his allergies to his primary care MD including influenza vaccine (he had in the past) which caused him diarrhea so he did not want o get another one. Pt has an egg allergy which likely is behind the influenza vaccine allergy. MD flagged pt's chart with influenza vaccine allergy.
Information has been received from a registered nurse concerning a 14 years old female patient who on 05-OCT-2010 was vaccinated intramuscularly into her left arm with her first 0.5ml dose of GARDASIL (lot number 665265/1378Y). Concomitant therapy included FLUVIRIN into her left arm. The nurse reported that on 06-OCT-2010 " a day after receiving her first dose of GARDASIL", the patient developed hives on the back of her upper arms and chest and she had pain in her left shoulder. On 07-OCT-2010, the patient recovered from hives on the back of her upper arms and chest and from pain in the left shoulder. The patient sought medical attention by a phone call. Additional information has been requested.
10 minutes after administering the flu vaccine (Flublok), she became flushed and tightness in throat.  Took to ED where she developed severe headache with right eye problem.  3 wks after injection she is still having vision problems, pressure/headache.
Severe muscle pain, large red rash at injection site, slight fever, pain in all joints, dizziness.
I lost usage of my lower extremities.Spent five days in hospital and 10 days in impatient rehab for PT/OT.  Continue PT/OT at home now.  Getting better slowly.; This is a spontaneous report from a contactable consumer (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 17May2021 14:15 (at the age of 32 years old) (Batch/Lot Number: ER2613) as dose 2, single for covid-19 immunization administered in a hospital. Medical history included known allergies: sulfa and Cephalosporines. Prior to vaccination, the patient was diagnosed with COVID-19. Concomitant medications included metoprolol, tolterodine l-tartrate (TOLTERODINE TARTRA) and aripiprazole (ABILIFY). The patient had the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: ER8737) via an unspecified route of administration in the left arm on 23Apr2021 08:15 (at the age of 32 years old) for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient lost usage of her lower extremities on 23Jun2021 10:00. She spent five days in hospital and 10 days in inpatient rehab for PT/OT. She continues PT/OT at home now. The patient is getting better slowly. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization and disability or permanent damage. The outcome of the event was recovering.  Follow-up attempts are completed. No further information is expected.
Patient passed out within 5-10 mins after receiving a flu vaccine. She fell forward while sitting and hit her head on a table in the waiting area. Forehead was bruised and bleeding.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On approximately November 2016, the patient received dose of M-M-R II (lot #, expiration date, exact dose and route of administration were not reported). It was reported that on approximately November 2016 (about 4 weeks ago), the patient had experienced a huge rash in the size of a two by three at the injection site within 48 hours of receiving the vaccine. The pharmacist stated that she viewed the patient's rash. No further information was provided. The outcome of the event was reported as not recovered. The relatedness between the event and M-M-R II was not provided. Additional information has been requested.
ADMITTED TO ER 5/13 WITH FLANK PAIN. TREATED AND RELEASED. THEN ADMITTED 12/31/2002 AND DIED 2/1/2002. DEATH SUMMARY: Physician Discharge Summary: Patient ID: MRN: UNKNOWN, Name: PRIVATE, Age: 58 y.o., Birthday:  12/6/1963, Admit Date: 1/31/2022  2:51 PM, Discharge Date: 2/1/2022, Unit: ICCU01/ICCU01A, Admitting Physician: Discharge Physician: PRIVATE, DO. Discharge Diagnosis: Principal Problem: Septic shock. Active Problems:- Essential hypertension, Acute respiratory failure, Metabolic acidosis, Acute renal failure with tubular necrosis, Anemia, COVID-19, Lymphoma, Leukocytosis, DM II (diabetes mellitus, type II), controlled. Hospital Course: Patient was admitted with severe acute renal failure and metabolic acidosis with pH 6.8 and hyperkalemia. He was 5 weeks post Covid-19 diagnosis. He was septic shock as well. He was started on broad spectrum ABX. He was initiated on CRRT as well as a bicarb drip. Despite this, he continued to deteriorate and required increased pressor demand. Off sedation, he had a GCS of 3. D dimer was found to be 35K. CTA was neg for PE. INR was 10 due to liver failure and heparin drip was not able to be started.  After 12 hours of SLED his K was still elevated at 7. His lactic was 19. His family was called in and they elected to transition him to comfort care. Cause of death septic shock with multisystem organ failure and severe metabolic acidosis due to renal failure. Associated comorbidities, COVID 19, Lymphoma, DM type 2. No new Assessment & Plan notes have been filed under this hospital service since the last note was generated. Service: Hospitalist Consults:   IP CONSULT TO NEPHROLOGY IP CONSULT TO NEPHROLOGY IP CONSULT TO VASCULAR SURGERY IP CONSULT TO PULMONOLOGY IP CONSULT TO ONCOLOGY/HEMATOLOGY IP CONSULT TO INFECTIOUS DISEASES.
FACE SWELLING; RASH ON FACE AND NECK; LOSS OF APPETITE; SKIN FEELS LIKE CRAWLING; This spontaneous report received from a patient concerned a 60 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: 21-SEP-2021) dose was not reported, administered on 27-JUL-2021 15:12 for prophylactic vaccination. No concomitant medications were reported.  On JUL-2021, the subject experienced skin feels like crawling. On 27-JUL-2021, the subject experienced loss of appetite. On 29-JUL-2021, the subject experienced face swelling. On 29-JUL-2021, the subject experienced rash on face and neck. Treatment medications included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from face swelling, rash on face and neck, and loss of appetite, and the outcome of skin feels like crawling was not reported. This report was non-serious.
Systemic: Allergic: Difficulty Breathing-Severe, Systemic: SOB from 48 hours post vaccine to present-Severe, Additional Details: 6'2\" 235lb adult male with no history of SOB reports abrupt onset of SOB 48 hours post vaccine to present (19 days later) with exertion, walking or talking. Physician reported neg for covid and normal EKG. Refered to cardiologist to continue investigation. Told to hold second dose.
2 minutes after vaccination, patient complained of dizziness and arm pain and was lowered to the ground. Patient became extremely disoriented. Initial vitals: BP 200/98, HR 110, Respirations 20, o2sat 99%. Patient started profusely vomiting. EMS was called. Patient was reoriented (AAOX4) however was still very dizzy. After EMS arrived, patient continued to experience dizziness and vomited. Patient was transported to hospital for further testing and observation.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a physician concerned a 55 year old male of unknown race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included: multiple sclerosis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced suspected clinical vaccination failure, suspected covid-19 infection and mild symptoms of covid-19. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from suspected covid-19 infection, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint.; Sender's Comments: V0:20220257506-COVID-19 VACCINE Ad26.COV2.S-suspected clinical vaccination failure . The event(s) has an unknown/unclear  temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
Given shots at 1:30, by 2:00 face and ears swollen. Pt given 1/2 tsp Zyrtec syrup daily for 5 days.
Feeling dizziness after 3 days of vaccine 2nd shot.; imbalance feeling; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP).   A 34-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 19May2021 16:00 (Lot number: EW0185) at the age of 34 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (dose number 1, lot number: EW0173, administration time: 16:00, vaccine location: Left arm), administration date: 28Apr2021, when the patient was 34 years old, for COVID-19 immunization. The following information was reported: DIZZINESS (non-serious) with onset 22May2021 09:00, outcome "not recovered", described as "Feeling dizziness after 3 days of vaccine 2nd shot."; BALANCE DISORDER (non-serious) with onset 22May2021, outcome "unknown", described as "imbalance feeling". Therapeutic measures were not taken as a result of dizziness.  Additional information: There was no other vaccine in four weeks. There was no other vaccine in two weeks. The patient was not diagnosed with Covid, prior vaccination. The patient was not diagnosed with Covid, post vaccination. There were no known allergies and no relevant tests. After 3 days of second dose of covid vaccine, patient started feeling dizziness never had any such experience before in his life. Contacted physician & explained his imbalance feeling. He concluded it may be due to age (34) covid vaccine could not have such impact. Looking for an answer for why felt such dizziness after second dose (3 days after).  No follow up attempts are possible. No further information is expected.
moderna covid-19 vaccine EUA loss of balance,,,,dizzy  required sitting down to keep from falling
I woke up at 3 A.M. the following morning with a bad migraine and dry mouth. I was also very nauseous so I went to my kitchen to have a glass of water. On the way back to the bedroom I felt my blood pressure bottom out and lost consciousness briefly and regained consciousness lying on the floor and my wife helping me up. I was able to make it to the bathroom and lay against the toilet because I thought I was going to throw up. I had that same feeling of my blood pressure dropping and again lost consciousness and regained consciousness with my head laying on the toilet seat. I also had sever chills and body aches, particularly in the neck area. I also struggled talking and communicating with my wife. She tells me I wasn?t making sense and my words were slurred.
couldn't concentrate at all or read the newspaper; extreme fatigue and exhaustion; slept 19 hours out of a 24 hour period; brain fog; This is a spontaneous report received from a contactable physician reporting for herself. A 73 years old female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL1283) at single dose via an unknown route in right arm on 08Feb2021 14:00 for Covid-19 immunization. Historical vaccine included 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL1284) on 18Jan2021 12:30 PM in right arm for Covid-19 immunization. Medical history included chronic mild-medium renal failure s/p left nephrectomy and adrenalectomy in 2017 due to left renal cancer, followed by severe renal failure one month p/o. Breast cancer p/o left mastectomy and reconstruction in 2005, hysterectomy in 2007, and mild hypertension which was treated. Patient had no known allergies to medications, food, or other products. Other medications the patient received within 2 weeks of vaccination included citalopram, bupropion, lisinopril, zolpidem, etc. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Feb2021 11:00, patient experienced extreme fatigue and exhaustion. Patient slept 19 hours out of a 24 hour period and had significant brain fog, where she couldn't concentrate at all or read the newspaper. No treatment was received for the events. Outcome of the events was resolved.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old male patient received BNT162b2 (BNT162B2), in Feb2022 as dose 4 (booster), single (Lot number: FJ4991), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Migraine" (unspecified if ongoing). Concomitant medication(s) included: LOPRESSOR; LIPITOR, stop date: 06Aug2022; EFFEXOR; PREVACID. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: strong positive; Negative, notes: almost negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Other medication in 2weeks reported as Lopressor, Lipitor, Effexor XR and Prevacid. It was reported that Covid-19 treatment from 06Aug2022 to 11Aug2022.
This spontaneous report was received from a licensed practitioner nurse refers to unspecified number of unspecified patients. Medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, an unspecified number of unspecified patients received improperly stored M-M-R II lot # K015375 and expiration date on 18-SEP-2015, (route, strength and dose were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from two nurses concerning a 68 year old female with allergies to morphine, amoxicillin, sulfonamides, aspirin, DAYPRO, CELEBREX, and codeine, hypertension, arthritis and hypothyroidism who on 11-AUG-2008 was vaccinated with the first dose of ZOSTER (Oka/Merck) (lot # 658325/1429U) into her left arm (also reported as 13-AUG-2008 by the follow up nurse).  Concomitant therapy included K-DUR, omeprazole, RESTASIS, SYNTHROID, metoprolol, AVAPRO, PREMARIN and ibuprofen.  On 28-AUG-2008, the patient experienced a rash type vesicular on the left side of her forehead in the supraorbital nerve distribution above in left eye with multiple vesicular lesions.  The patient was examined by her primary physician and unspecified ophthalmologist on that day.  She did not have any recent chicken pox or shingles exposure.  The physician noted an early shingles rash above the left eye and described it as herpes ZOSTER and prescribed ZOVIRAX as well as CLOBETASONE topical cream.  The eye exam was normal.  The patient had a follow-up appointment in one week.  At the time of the report, the patient's shingles and rash on the left side of her forehead persisted.  The sample of the lesion was collected on 02-SEP-2008.  The sample was taken from a vesicular lesion (site not specified).  The results of the varicella ZOSTER virus identification polymerase chain reaction test were: The VZV DNA was amplified, which showed the wild-type and it was not B-globin DNA amplified.  Interpretacion: Adequate specimen, wild type strain.  Additional information has been requested.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history and concomitant therapies were not reported. Between 03-SEP-2017 and 11-SEP-2017, the patient was vaccinated with an improperly stored dose of PEDVAXHIB (lot # M003701, expiration date 01-NOV-2019 and lot # N003700, expiration date 01-NOV-2019) (dose and route were not reported) for prophylaxis. The vaccine was exposed to 8.5 Celsius degrees (°C) for 1 hour. There was no previous temperature excursion and also there was no "data logger". No adverse effects were reported. Lot number M003701 is an invalid lot number for haemophilus b conjugate vaccine (meningococcal protein conjugate). This is one of several reports from the same reporter. Sender's Comments: US-009507513-1709USA009437: US-009507513-1709USA009443: US-009507513-1709USA009439: US-009507513-1709USA009440: US-009507513-1709USA009441: US-009507513-1709USA009442: US-009507513-1709USA009436: US-009507513-1709USA005606: US-009507513-1709USA009438.
Patient is 17  years of age and vaccine is recommended for 18 years old and up. no adverse effects reported.
Pt reported to pharmacy about 8 weeks after receiving Moderna booster dose at our pharmacy. He reported for the last 6 weeks he had fatigue, extensive weight loss, lack of appetite, frequent urination. Pt stated vaccination was only change to regular lifestyle. I recommended immediate follow up at nearby urgent care clinic, but patient seemed hesitant to go.
Tinnitis. Onset 02Apr. More pronounced in right ear but persistent 24/7 in both.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533), via an unspecified route of administration in the left arm on 31Mar2021 at 10:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took bacitracin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. On 02Apr2021 at 08:00, the patient experienced tinnitus that was more pronounced in right ear but persistent 24/7 in both. The patient had no prior history of tinnitus. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus that was more pronounced in right ear but persistent 24/7 in both was not resolved at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 21Apr2021 at 16:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are needed. No further information is expected.
Patient completed consent stating he received previous vaccine noting it was Moderna Covid 19 vaccine. Here for 2nd dosage but did not have his vaccine card available at time 2nd dose was given.  This nurse gave 2nd dose of Moderna Covid19 in LD with no adverse reaction at time of service. Returned with vaccine card to complete 2nd dose entry and noted 1st dose was actually Pfizer Covid 19 mRNA vaccine. Patient states and presents with no adverse reaction at that time. Follow up 6 days later on 7/6/2021 and still no adverse reaction noted. This incident was reported on site and entered into system as well with in the 24 hr time requirement and Completed VAERS. No further follow up needed at this time.